K. Saboundji

Sign up to set email alerts
|
7Publications
50Citation Statements Received
125Citation Statements Given
How they've been cited
47
4
46
0
How they cite others
112
12
113
0
Publications
Order By: Most citations

Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors

Saboundji1,
Auliac2,
Pérol
3
et al. 2018
Targ Oncol
40
3
32
0
View full textAdd to dashboardCite
show abstract

Real-Life Efficacy of Osimertinib in Pretreated Octogenarian Patients with T790M-Mutated Advanced Non-small Cell Lung Cancer

Auliac1,
Saboundji
2
,
Meynier
3
et al. 2019
Targ Oncol
7
1
14
0
View full textAdd to dashboardCite

Tolérance et efficacité de l’osimertinib chez les patients (pts) octogénaires atteints de cancer du poumon non à petites cellules (CPNPC) porteurs d’une mutation T790M de l’Epidermal Growth Factor Receptor (EGFR) pré-traités par inhibiteurs de tyrosine-kinase (ITK) de l’EGFR. Étude Explore T790M, cohorte octogénaire

Saboundji1,
Auliac2,
Fraboulet
3
et al. 2019
Revue des Maladies Respiratoires
0
0
0
0
View full textAdd to dashboardCite

Efficacité de la combinaison paclitaxel hebdomadaire – bevacizumab pour les patients avec un cancer bronchopulmonaire non à petites cellules non épidermoïdes (CBNPC) : AVATAX, une étude rétrospective multicentrique

Bilger1,
Toffart
2
,
Darasson3
et al. 2021
Revue des Maladies Respiratoires Actualités
0
0
0
0
View full textAdd to dashboardCite

Activité de l’osimertinib dans les méningites carcinomateuses des cancers non à petites cellules (CPNPC) avec mutation activatrice de l’EGFR ayant déjà bénéficié d’un traitement par inhibiteur tyrosine-kinase (TKI) de l’EGFR

Saboundji1,
Auliac2,
Pérol
3
et al. 2018
Revue des Maladies Respiratoires
0
0
0
0
View full textAdd to dashboardCite

Aspects clinique, thérapeutique et pronostique chez 11 cas de sarcoïdose systémique pris en charge au CHU de Tizi Ouzou de 2011 à 2015

Amrani1,
Hammache2,
Saboundji3
et al. 2016
Revue des Maladies Respiratoires
0
0
0
0
View full textAdd to dashboardCite

Évaluation de la prescription de l’antibiothérapie dans les pneumonies communautaires de sévérité modérée hospitalisées dans le service de pneumologie de Tizi Ouzou (Algérie)

Saboundji
1
,
Hammache
2
,
Fissah
3
et al. 2016
Revue des Maladies Respiratoires
0
0
0
0
View full textAdd to dashboardCite
1
scite logo

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Product
Browser ExtensionAssistant by sciteCitation Statement SearchReference CheckVisualizationsDashboardsExplore JournalsExplore OrganizationsExplore FundersEmbedding BadgeEmbedding Citation SearchPricing
Resources
BlogHelp & FAQAccessibility StatementAPI TermsFor Universities & GovernmentsFor ResearchersFor PublishersFor Corporate, Pharma & EnterpriseAuthor MarketingBecome an AffiliateGet an organization trial or quotescite Data & Services
About
News & PressCareersRead our PaperCoverage

BlogTerms and ConditionsAPI TermsPrivacy PolicyContactCookie PreferencesDo Not Sell or Share My Personal Information

Copyright © 2024 scite LLC. All rights reserved.

Made with 💙 for researchers

Part of the Research Solutions Family.